(R/S)-N-methyl-1-(4,5,6,8-tetrahydrothieno[2,3-c]oxepin-8-yl)methanamine

ID: ALA5076544

PubChem CID: 166625859

Max Phase: Preclinical

Molecular Formula: C10H15NOS

Molecular Weight: 197.30

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNCC1OCCCc2ccsc21

Standard InChI:  InChI=1S/C10H15NOS/c1-11-7-9-10-8(4-6-13-10)3-2-5-12-9/h4,6,9,11H,2-3,5,7H2,1H3

Standard InChI Key:  QSVFBEFJPQNHHR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 13 14  0  0  0  0  0  0  0  0999 V2000
   35.3347  -23.8533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8161  -23.1832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3274  -22.5185    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   33.1429  -22.4822    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.8178  -23.2348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1927  -23.9146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9192  -22.2870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5423  -22.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5487  -23.6027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9561  -24.0802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0914  -21.4765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4758  -20.9220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6877  -21.1780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9  1  1  0
  1  2  2  0
  2  3  1  0
  3  8  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  8  9  2  0
  9 10  1  0
 10  6  1  0
  7  8  1  0
  7 11  1  0
 11 12  1  0
 12 13  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5076544

    ---

Associated Targets(Human)

TAAR1 Tclin Trace amine-associated receptor 1 (1397 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 197.30Molecular Weight (Monoisotopic): 197.0874AlogP: 1.97#Rotatable Bonds: 2
Polar Surface Area: 21.26Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.26CX LogP: 1.94CX LogD: 0.09
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.78Np Likeness Score: -0.68

References

1. Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L..  (2022)  Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia.,  13  (1.0): [PMID:35047111] [10.1021/acsmedchemlett.1c00527]

Source